Most Anticipated Trial Results Regarding Biomarkers in RCC

Most Anticipated Trial Results Regarding Biomarkers in RCC

obr

11 months
417 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains the anticipated trial results involving I-O, TKIs and biomarkers in renal cell carcinoma (RCC).
Up Next Autoplay